Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Abbott
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Switzerland Supplementary Protection Certificates

See Plans and Pricing

« Back to Dashboard

Supplementary Protection Certificates in Switzerland

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
Country Patent Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration
European Patent Office 1355673 C01355673/01 Switzerland PRODUCT NAME: POLYSACCHARIDA NEISSERIAE MENINGITIDIS A/C/W/Y, PROTEINUM CORYNEBACTERIAE DIPHTERIAE CRM197; CONJUGATUM; REGISTRATION NO/DATE: SWISSMEDIC 60079 10.03.2011   Start Trial
European Patent Office 1912999 C01912999/01 Switzerland PRODUCT NAME: SIMEPREVIR; REGISTRATION NO/DATE: SWISSMEDIC 63215 04.03.2015   Start Trial
European Patent Office 1539200 C01539200/01 Switzerland PRODUCT NAME: DACLIZUMAB BETA; REGISTRATION NO/DATE: AUTORISATION SWISSMEDIC 66069 26.01.2017   Start Trial
European Patent Office 2475353 C02475353/01 Switzerland PRODUCT NAME: RITUXIMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65813 28.06.2016   Start Trial
European Patent Office 1581254 C01581254/01 Switzerland PRODUCT NAME: MICROPLASMIN (OCRIPLASMIN); REGISTRATION NO/DATE: SWISSMEDIC 63053 13.03.2014   Start Trial
European Patent Office 0911342 C00911342/01 Switzerland PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: SWISSMEDIC 60210 03.08.2010   Start Trial
European Patent Office 1267866 C01267866/02 Switzerland FORMER OWNER: SOSEI R&D LTD., GB   Start Trial
>Country >Patent Number >Supplementary Protection Certificate >SPC Country >SPC Description >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Abbott
Moodys
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.